ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
8 announcements
Max-Bio Biosciences acquired 21,42,857 shares (11.89% stake) in Raconteur Global Resources via preferential allotment. The non-promoter acquirer held no prior stake in the company.
Raconteur Global Resources has appointed A S Bhutani & Associates as Statutory Auditor and Sourabh Parnami and Arvinder Singh Kohli as Non-Executive Independent Directors.
Raconteur Global Resources held its 8th Annual General Meeting on 18th September, 2026. The meeting covered financial adoption, appointments, and preferential issue resolutions.
Raconteur Global Resources issued a corrigendum to its 8th AGM notice, clarifying details on Resolution 7 & 8 regarding a proposed ₹30 Crore preferential issue.
Raconteur Global Resources Limited issued a corrigendum to its 8th AGM notice, amending details for Resolutions 7 and 8 concerning its proposed preferential issue.
Raconteur Global Resources corrected a meeting-time typo and provided allottee details for 47,49,999 shares allotted on warrant conversion at ₹14 per share. Total consideration is ₹6.65 Crore.
Raconteur Global Resources allotted 47,49,999 equity shares at ₹14 each upon conversion of warrants to non-promoter investors. Total issue value is approximately ₹6.65 Crore.
Raconteur Global Resources Ltd reported revenue from operations of ₹3.7 Cr (+640.0% YoY) and a net loss of ₹20.5 Cr for H2 FY26.